Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Jollimine 250mg Capsule
Jollimine 250mg Capsule
Manufacturer/Marketed By : JOLLY HEALTHCARE
$1.84 $1.75
Jollimine 250mg capsule contains the active substance penicillamine. Primarily it is a chelating agent, which means it can bind to certain metals in your body, including copper and lead, to...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
PENICILLAMINE
Active Pharmaceutical Ingredient
Jollimine 250mg Capsule
1,84 US$
1,75 US$
Jollimine 250mg capsule contains the active substance penicillamine. Primarily it is a chelating agent, which means it can bind to certain metals in your body, including copper and lead, to help remove them from your body. It is used to treat Wilson’s disease and lead poisoning. It also belongs to a group of medicines called DMARDS (disease-modifying antirheumatic drugs). It helps to relieve the pain and stiffness caused by rheumatoid arthritis in adults and children. It also treats still’s diseases in children. Jollimine 250mg capsule also treats a kidney problem called cystinuria in adults and children. It is also indicated to treat chronic active hepatitis (a type of liver disease) in adults. Do not take this medicine if you are allergic to penicillamine or any of the other ingredients of this medicine. Do not take this medicine if you have ever had a reduction in WBC after taking this medicine. Do not take this medicine if you have ever had aplastic anemia (severe reduction in blood cells), lupus erythematosus (an allergic condition that causes skin rashes), or kidney problems. Do not consume this medicine if you have ever had thrombocytopenia (a blood disorder that causes bleeding into your skin, bruising, and more bleeding than usual after an injury). Inform your physician if you have protein in your urine, if you are pregnant or breastfeeding, if you have blood in your urine, if you have an active infection, and if you are an elderly patient. Your doctor will recommend you take complete blood and urine tests before initiating the treatment.
Active Pharmaceutical Ingredient
Usos
• Relieve pain and stiffness caused by rheumatoid arthritis.
• Treats lead poisoning
• Treats Still’s disease in children
• Treats Wilson’s disease
• Treats cystinuria
• Chronic active hepatitis
Beneficios
As a chelating agent, Jollimine 250mg capsule chelates mercury, lead, copper, iron, and probably other heavy metals to form stable, soluble complexes that are readily excreted in the urine. In cystinuria, it lowers excess cystine excretion. It also inhibits the production of tropocollagen cross-links and cleaves them when newly created. The method of action in rheumatoid arthritis is uncertain; however, it appears to reduce disease activity.
Efectos secundarios
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Efectos secundarios más comunes
• Injection site reaction
• Inflammation of the pancreas
• Renal injury
• Liver problems
• Muscle weakness
Efectos secundarios comunes
• Rash
• Diarrhea
• Epigastric pain, loss of appetite
• Loss of taste
• Nausea, mouth ulcer
• Vomiting
• Decreased bone marrow activity
• Protein in urine
Cómo utilizar
Take the medicine as prescribed by your doctor. Your doctor will decide the dose and duration of the treatment based on the disease condition and other factors. Swallow the capsules as a whole with a glass of water. Do not break, chew, crush, or dissolve the capsules. Take the capsules on an empty stomach.
Consejos de seguridad
• Breast Feeding: Breastfeeding is not recommended in patients taking Jollimine 250mg capsule because the medicine passes into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether consuming alcohol is safe during the treatment with Jollimine 250mg capsule. Inform your doctor if you are a chronic drinker.
• Liver: Jollimine 250mg capsule should be used cautiously in patients with liver disorders. Consult your doctor if you have any liver problems before starting the treatment.
• Lungs: It is unknown whether Jollimine 250mg capsule can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Jollimine 250mg capsule does not affect the ability to drive. If you feel tired or dizzy after taking this medicine, do not drive and consult your doctor for more advice.
• Pregnancy: Jollimine 250mg capsule is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.



